Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-17T18:51:20.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision history now shows an addition of Revision: v3.3.2 and removal of Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-26T08:27:53.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page removed a government funding notice, which is a minor administrative change and does not affect the study record or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-19T08:43:24.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new version entry was added to the Record History, showing an updated submission date. No core study data appear to be altered.
    Difference
    0.0%
    Check dated 2025-10-28T05:22:27.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    - Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.
    Difference
    7%
    Check dated 2025-10-06T16:28:51.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T10:19:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.